This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by DVM, G. H. H. Articles by Pachter, I. J. Search for Related Content PubMed Articles by DVM, G. H. H. Articles by Pachter, I. J. Social Bookmarking                         What's this?

An Analysis of the Carcinogenesis Testing Experience of the National Cancer Institute

Pharmaceutical Research and Development Division, Bristol-Myers Company, PO Box 657, Syracuse, New York 13201

I. J. Pachter, Ph.D.

Pharmaceutical Research and Development Division, Bristol-Myers Company, PO Box 657, Syracuse, New York 13201

Tabulations of the results of the initial approximately 200 NCI carcinogenesis bioassays conducted in mice and rats were published recently. However, no analysis of the results were provided. Such an analysis is the subject of this report.

Ninety eight NCI bioassays were positive for carcinogenicity. Only three bioassays (<2%) were negative in both species and the ratio of positive to negative bioassays was 33:1. The remaining 47% of the bioassays were considered to be suggestive or inconclusive and it is inappropriate to refer to the total positive rate as 50%. The liver was the predominant tumor site and the only tumors produced in either rodent species in 19% of the positive bioassays were in the livers of mice. The high ratio of positive to negative results and the use of the mouse liver as a discriminating target organ raise serious concerns about the carcinogenesis protocol and in the methods of evaluating the results. Several recommendations are offered which may be useful in the current reexamination of bioassay procedures.

Toxicologic Pathology, Vol. 10, No. 1, 22-26 (1982)
DOI: 10.1177/019262338201000103


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. H. Hottendorf Carcinogenicity Testing of Antitumor Agents Toxicol Pathol, April 1, 1985; 13(3): 192 - 199. [Abstract] [PDF]

				G. H. Hottendorf and I. J. Pachter Review and Evaluation of the NCI/NTP Carcinogenesis Bioassays Toxicol Pathol, February 1, 1985; 13(2): 141 - 146. [Abstract] [PDF]